{"filing":{"accession_number":"0001213900-26-098880","cik":"0001795091","ticker":"OSTX","company_name":"OS Therapies Inc","form":"8-K","filing_date":"2026-09-10","report_date":"2026-09-10","primary_document":"ea0305135-8k_ostherapies.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1795091/000121390026098880/ea0305135-8k_ostherapies.htm"},"events":[{"id":32752,"run_id":30112,"accession_number":"0001213900-26-098880","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The filing discloses a prospectus supplement covering the resale of 5,874,094 shares of common stock by selling stockholders under a Form S-3 registration statement. This represents a dilutive equity issuance that increases the float and potential shareholder dilution. The Company is providing legal counsel's opinion on the legality of the shares, which is a standard disclosure mechanism for registered secondary offerings and resales that materially affect the capital structure.","company_name":"OS Therapies Inc","ticker":"OSTX","filing_date":"2026-09-10","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":36005,"accession_number":"0001213900-26-098880","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a prospectus supplement covering the resale of 5,874,094 shares of common stock by selling stockholders under a Form S-3 registration statement. This represents a dilutive equity issuance that increases the float and potential shareholder dilution. The Company is providing legal counsel's opinion on the legality of the shares, which is a standard disclosure mechanism for registered secondary offerings and resales that materially affect the capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T21:28:44.326485+00:00","company_name":"OS Therapies Inc","ticker":"OSTX","filing_date":"2026-09-10"}]}